Evital, unapproved by FDA, May be Ineffective and Unsafe

Advertisement

The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital.

Evital, not been approved by the FDA for use in the U.S., may be counterfeit versions of the “morning after pill” and may not be safe or effective in preventing pregnancy.

This potentially ineffective and suspect counterfeit emergency birth control may also be in distribution in some Hispanic communities in the United States.

The packaging label of the potentially ineffective and suspect counterfeit version says, “Evital Anticonceptivo de emergencia, 1.5 mg, 1 tablet”, by “Fluter Domull”,(see picture below):

Consumers should not take the Evital product if its packaging looks like the picture above.

Advertisement

Keep in mind:

  1. Contact your doctor or health care professional if you have taken Evital labeled as the 1.5 mg tablet and experienced any problems.
  2. There are FDA-approved emergency birth control medicines available both with a prescription, and over-the-counter without a prescription (if you are 17 years old or older).
  3. You should talk with a doctor, pharmacist, or health care professional to find the FDA-approved emergency birth control medicine best for you.

FDA is asking for help from consumers who have information about Evital.

Please send an email to [email protected] to provide information or if you have more questions.

Any information received is confidential and will be used only to help in FDA’s effort to remove the potentially unsafe and ineffective versions from the U.S. marketplace.

Health care professionals and consumers are asked to report adverse events related to the use of suspect counterfeit versions of Evital to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program either online, by regular mail, by fax, or by phone.

Complete and submit the report online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

Source
Food and Drug Administration

Advertisement